Inventor · disambiguated record
Lawren Wu
Also filed as: WU LAWREN · WU LAWREN C
11 granted patents·8 pending applications·242 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
19 records- 0197US7662926B2Anti-Fc-gamma receptor antibodies, bispecific variants and uses thereforGENENTECH INC·Filed 2007·Granted Feb 16, 2010·85 cites·39 claims
- 0294US8071097B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2008·Granted Dec 6, 2011·34 cites·64 claims
- 0394US7655229B2Anti-FC-gamma RIIB receptor antibody and uses thereforCHAN ANDREW C·Filed 2007·Granted Feb 2, 2010·93 cites·40 claims
- 0492US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0586US10597456B2Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Mar 24, 2020·6 cites·46 claims
- 0685US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 0784US8586040B2Methods of using apoptotic anti-IGE antibodiesWU LAWREN·Filed 2011·Granted Nov 19, 2013·6 cites·50 claims
- 0883US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 0982US8632775B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2011·Granted Jan 21, 2014·4 cites·7 claims
- 1082US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1181US8618274B2Nucleic acid encoding apoptotic anti-IgE antibodiesWU LAWREN·Filed 2011·Granted Dec 31, 2013·4 cites·35 claims
- 1273US2023331855A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1366US2023124464A1Chimeric receptors to flt3 and methods of use thereofAMGEN INC·Filed 2022·Application pending·0 cites
- 1464US2020115457A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2019·Application pending·0 cites
- 1561US2014115729A1Apoptotic anti-ige antibodiesGENENTECH INC·Filed 2013·Application pending·0 cites
- 1647US12012462B2Chimeric receptors to DLL3 and methods of use thereofAMGEN INC·Filed 2019·Granted Jun 18, 2024·0 cites·14 claims
- 1741US2006073142A1Anti-Fc-gamma RIIB receptor antibody and uses thereforGENENTECH INC·Filed 2005·Application pending·0 cites
- 1835US2016207995A1Anti-il-4 antibodies and bispecific antibodies and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 1935US2017334985A1Anti-il-13/il-17 bispecific antibodies and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lawren Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →